Ke Su

1.0k total citations
39 papers, 514 citations indexed

About

Ke Su is a scholar working on Surgery, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Ke Su has authored 39 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 15 papers in Hepatology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Ke Su's work include Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Cancer Mechanisms and Therapy (7 papers). Ke Su is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Cancer Mechanisms and Therapy (7 papers). Ke Su collaborates with scholars based in China, United States and Germany. Ke Su's co-authors include Haisen Zhang, Hao Liu, Jun Wang, Ke Xu, Hao Chi, Tao Gu, Han Li, Lu Guo, Yunwei Han and Hao Zeng and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Analytical Chemistry.

In The Last Decade

Ke Su

34 papers receiving 510 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ke Su China 12 142 119 95 95 94 39 514
Masato Kitazawa Japan 13 132 0.9× 284 2.4× 73 0.8× 104 1.1× 163 1.7× 69 689
Dongbao Zhao China 17 133 0.9× 246 2.1× 81 0.9× 44 0.5× 70 0.7× 31 848
Tianshu Liu China 16 104 0.7× 211 1.8× 35 0.4× 263 2.8× 348 3.7× 91 809
Marijana Ćorić Croatia 13 242 1.7× 136 1.1× 15 0.2× 120 1.3× 61 0.6× 70 528
Hayahito Nomi Japan 14 147 1.0× 246 2.1× 109 1.1× 172 1.8× 126 1.3× 52 627
Jianguang Qiu China 16 111 0.8× 246 2.1× 116 1.2× 228 2.4× 85 0.9× 52 672
Yong Il Kim South Korea 7 181 1.3× 39 0.3× 63 0.7× 111 1.2× 139 1.5× 21 448
Renato Colella Italy 17 266 1.9× 185 1.6× 33 0.3× 285 3.0× 261 2.8× 40 847
D. Baumunk Germany 13 181 1.3× 99 0.8× 111 1.2× 233 2.5× 27 0.3× 47 571
Qian Xia China 12 84 0.6× 91 0.8× 9 0.1× 31 0.3× 108 1.1× 35 521

Countries citing papers authored by Ke Su

Since Specialization
Citations

This map shows the geographic impact of Ke Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Su more than expected).

Fields of papers citing papers by Ke Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Su. The network helps show where Ke Su may publish in the future.

Co-authorship network of co-authors of Ke Su

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Su. A scholar is included among the top collaborators of Ke Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Su. Ke Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Su, Ke, Xin Liu, Yue‐Can Zeng, et al.. (2025). Machine Learning Radiomics for Predicting Response to MR-Guided Radiotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter Cohort Study. Journal of Hepatocellular Carcinoma. Volume 12. 933–947.
3.
4.
5.
Jiang, Xiumei, Pan Wang, Ke Su, et al.. (2024). Camrelizumab combined with transcatheter arterial chemoembolization and sorafenib or lenvatinib for unresectable hepatocellular carcinoma: A multicenter, retrospective study. Annals of Hepatology. 30(2). 101578–101578. 3 indexed citations
6.
Li, Han, Chenjie Wang, Bo Li, et al.. (2024). Lasso-Cox interpretable model of AFP-negative hepatocellular carcinoma. Clinical & Translational Oncology. 27(1). 309–318. 2 indexed citations
7.
Su, Ke, Weihong Huang, Ke Xu, et al.. (2023). Evaluation of Lactate Dehydrogenase and Alkaline Phosphatase as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram. Journal of Hepatocellular Carcinoma. Volume 10. 69–79. 30 indexed citations
8.
Su, Ke, Binghua Li, Ye Wang, et al.. (2023). Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective study. BMC Cancer. 23(1). 1081–1081. 4 indexed citations
9.
Zhao, Songyun, Hao Chi, Qian Yang, et al.. (2023). Identification and validation of neurotrophic factor-related gene signatures in glioblastoma and Parkinson’s disease. Frontiers in Immunology. 14. 1090040–1090040. 63 indexed citations
10.
11.
Han, Li, Ke Su, Ke Xu, et al.. (2023). PD-1 Inhibitors Combined with Antiangiogenic Therapy with or Without Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Propensity Matching Analysis. Journal of Hepatocellular Carcinoma. Volume 10. 1257–1266. 12 indexed citations
12.
Su, Ke, Tao Gu, Ke Xu, et al.. (2023). Construction and validation of a nomogram for HBV-related hepatocellular carcinoma: A large, multicenter study. Annals of Hepatology. 28(4). 101109–101109. 30 indexed citations
13.
Wu, Shengyu, Shuyuan Xian, Weiwei Zhang, et al.. (2023). Construction of Metastasis-Specific Regulation Network in Ovarian Cancer Based on Prognostic Stemness-Related Signatures. Reproductive Sciences. 30(9). 2634–2654. 3 indexed citations
14.
Chen, Jiali, et al.. (2023). Different types of fruit intake and colorectal cancer risk: A meta-analysis of observational studies. World Journal of Gastroenterology. 29(17). 2679–2700. 11 indexed citations
15.
Peng, Gaoge, Hao Chi, Jinhao Zhang, et al.. (2022). Identification and validation of neurotrophic factor-related genes signature in HNSCC to predict survival and immune landscapes. Frontiers in Genetics. 13. 1010044–1010044. 36 indexed citations
16.
Jiang, Yuchao, Shuxia Chen, Ke Su, et al.. (2021). Rare variants in TULP3 abolish the suppressive effect on sonic hedgehog signaling and contribute to human neural tube defects. Genes & Diseases. 9(5). 1174–1177. 5 indexed citations
17.
Su, Ke, et al.. (2019). Thiazide Diuretics and the Incidence of Osteoporotic Fracture: A Systematic Review and Meta-Analysis of Cohort Studies. Frontiers in Pharmacology. 10. 1364–1364. 14 indexed citations
18.
19.
Su, Ke, Song Liu, Tao Wu, et al.. (2017). Posterior column acetabular fracture fixation using a W-shaped angular plate: A biomechanical analysis. PLoS ONE. 12(11). e0187886–e0187886. 13 indexed citations
20.
Su, Ke. (2002). Influence of puerarin on insulin resistance in non-insulin dependent diabetes mellitus. Chinese Journal of New Drugs and Clinical Remedies. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masato Kitazawa Breakdown of academic impact, for papers by Dongbao Zhao Breakdown of academic impact, for papers by Tianshu Liu Breakdown of academic impact, for papers by Marijana Ćorić Breakdown of academic impact, for papers by Hayahito Nomi Breakdown of academic impact, for papers by Jianguang Qiu Breakdown of academic impact, for papers by Yong Il Kim Breakdown of academic impact, for papers by Renato Colella Breakdown of academic impact, for papers by D. Baumunk Breakdown of academic impact, for papers by Qian Xia
Rankless by CCL
2026